Highlights Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Market Closed - Canadian Securities Exchange Other stock markets 03:43:26 2024-04-22 pm EDT			5-day change	1st Jan Change
0.03 ^CAD	+20.00%		0.00%	-40.00%

Mar. 26	Psyence Group Closes Strategic Restructuring of Its Non-Clinical Business	MT
Mar. 26	An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	Mar. 25	CI
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	Mar. 11	MT
An undisclosed buyer entered into a conditional agreement to acquire Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc. for CAD 1 million.	Mar. 10	CI
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 28	CI
Psyence Biomedical Approved to List on Nasdaq Following Completion of Business Combination With Newcourt Acquisition Corp	Jan. 26	MT
Psyence Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 10	CI
Psyence Group Inc. Designs New Laboratory at Facility in Order to Expand its Extraction Capabilities	23-10-30	CI
Psyence Group Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-28	CI
Psyence Group Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-27	CI
Psyence Group Inc. Partners with iNGEN for Palliative Care Clinical Trial in Australia	23-03-21	CI
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-03-01	CI
Psyence Group and Eden Labs Announce Extraction and Product Development Collaboration	23-01-24	MT
Psyence Group Inc. and Eden Labs LLC Announces Extraction and Product Development Collaboration	23-01-24	CI
Psyence Group Completes Export of Pharma Grade Psilocybin Extract to UK	23-01-20	CI
Psyence Group Completes Export of Pharma Grade Psilocybin Extract to UK	23-01-20	MT
Refile: Psyence Details Business Combination Between Subsidiary Psyence Biomed and Nasdaq-listed Newcourt Acquisition Corp	23-01-10	MT
Psyence Details Business Combination Between Subsidiary Psyence Biomed and Nasdaq-listed Newcourt Acquisition Corp	23-01-10	MT
Psyence Announces Business Combination between Wholly Owned Subsidiary Psyence Biomed Corp. and Nasdaq listed Newcourt Acquisition Corp	23-01-09	GL
Psyence Announces Business Combination between Wholly Owned Subsidiary Psyence Biomed Corp. and Nasdaq listed Newcourt Acquisition Corp	23-01-09	AQ
Psyence Group Inc. Signs Letter of Intent with INGENu CRO Pty Ltd	23-01-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Highlights

Filters